Previous close | 2.0000 |
Open | 0.0000 |
Bid | 0.0000 x N/A |
Ask | 0.0000 x N/A |
Day's range | 0.0000 - 0.0000 |
52-week range | |
Volume | |
Avg. volume | 8,763 |
Market cap | N/A |
Beta (5Y monthly) | 1.20 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.4160 |
Earnings date | 09 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Performance Surpasses Revenue Estimates but Misses on EPS
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q1 2024 Earnings Call Transcript May 9, 2024 Xeris Biopharma Holdings, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, everyone, and welcome to the Xeris Biopharma First Quarter 2024 Financial Results Conference Call […]
Xeris Biopharma Holdings ( NASDAQ:XERS ) First Quarter 2024 Results Key Financial Results Revenue: US$40.6m (up 22...